GlassScriptPhysician profile
Sammi Dali
NPI 1407825722
$16,640.61
in general payments reported to CMS, 2019-2025
37 companies · $2,192 in 2025
The $2,192 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,975 · 2020: $1,043 · 2021: $2,547 · 2022: $2,803 · 2023: $3,012 · 2024: $2,069 · 2025: $2,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,775 · Food and Beverage: $2,324 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,774.77 |
| Food and Beverage | $2,324.15 |
| Education | $174.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $3,497.42 | 2019-2025 | Gore Cardioform Septal Occluder |
| Medtronic, INC. | $2,305.47 | 2022-2025 | Corevalve Evolut R |
| Terumo Medical Corporation | $1,748.43 | 2024 | Glidesheath Slender, Optitorque, Glidewire |
| Abbott Laboratories | $1,542.10 | 2019-2025 | Navitor, Amplatzer, Ensite |
| Janssen Pharmaceuticals, INC | $988.59 | 2019-2022 | |
| Medical Device Business Services, INC. | $789.53 | 2023 | Carto 3 |
| Novartis Pharmaceuticals Corporation | $742.92 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $498.95 | 2019-2022 | |
| Boston Scientific Corporation | $496.53 | 2020-2025 | General - Structural Heart, Watchman Flx |
| Amgen INC. | $474.07 | 2019-2022 | |
| Esperion Therapeutics, INC. | $421.68 | 2020-2022 | |
| Cook Medical LLC | $315.19 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $304.15 | 2019-2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $297.29 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $252.18 | 2019-2025 | Lifevest |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $214.99 | 2019-2022 | |
| Vifor Pharma, INC. | $209.17 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $195.15 | 2020-2021 | |
| Edwards Lifesciences Corporation | $168.15 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kowa Pharmaceuticals America, INC. | $167.63 | 2020-2022 | |
| Abiomed | $146.91 | 2019 | |
| Penumbra, INC. | $144.38 | 2024 | Indigo System |
| Teleflex LLC | $114.54 | 2022-2023 | Manta |
| Merck Sharp & Dohme LLC | $111.76 | 2021-2022 | |
| Chiesi USA, INC. | $99.65 | 2019-2023 | Cleviprex, Kengreal |
| Actelion Pharmaceuticals US, INC. | $86.33 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $52.91 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $47.48 | 2019 | |
| Cardiovascular Systems INC. | $36.61 | 2020-2021 | |
| Lundbeck LLC | $35.43 | 2020 | |
| Amryt Pharma Holdings LTD | $30.43 | 2021 | |
| Gilead Sciences, INC. | $26.25 | 2019 | |
| United Therapeutics Corporation | $21.66 | 2021 | |
| Angiodynamics, INC. | $15.86 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.46 | 2022 | |
| Shockwave Medical, INC | $13.76 | 2021 | |
| Lilly USA, LLC | $12.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sammi Dali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.